HOME >> MEDICINE >> NEWS
The Eli and Edythe Broad Foundation invests in gastroenterology's future

The American Gastroenterological Association (AGA) and its Foundation for Digestive Health and Nutrition (FDHN) today announced a three-year grant from the Eli and Edythe Broad Foundation, which will benefit high school students who demonstrate high potential for careers in digestive disease research. The Student Research Fellowship Awards program was created by the AGA more than a decade ago to stimulate interest in gastroenterological (GI) research careers in high school, college and medical school students.

Youth are the future of scientific research, noted Sidney Cohen, MD, AGAF, Chairman of the Foundation. Our Foundation has recognized the need to begin fostering an interest in the field at the earliest point in a students academic career.

The Eli and Edythe Broad Student Research Fellowships will provide five students with $2,500 each to fund a 10-week session of research in digestive diseases or nutrition under the supervision of an approved preceptor. Preceptors are AGA members who serve as full-time faculty members at accredited North American institutions.

The 2007 AGA Foundation Broad Scholars are:

  • Jane Li
    Westwood High School, Austin, Texas
    Research location: Dallas VA Medical Center
    Role of Oncogenic Ras in the Neoplastic Progression of Barretts Esophagus

  • Yuan Tao
    Gunn High School, Palo Alto, California
    Research location: Palo Alto VA Hospital
    Monitoring of apoptosis in liver diseases with a novel keratin-cleavage specific antibody

  • Alice B. Conant
    Phillips Andover Academy, Andover, Massachusetts
    Research location: University of Pennsylvania School of Medicine
    Association of physical activity and biomarkers on colorectal cancer risk

  • Laura G. Mirviss
    Montgomery Blair High School, Silver Spring, Maryland
    Research location: Johns Hopkins School
    '"/>



Contact: Aimee Frank
media@gastro.org
301-468-7644
American Gastroenterological Association
25-Jul-2007


Page: 1 2

Related medicine news :

1. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
2. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
3. Rosenzweig to head Leducq Foundation cardiovascular research grant
4. UCSF pharmacy school receives major grant from Amgen Foundation for Medicare Part D outreach
5. Woodruff Foundation gives major boost to Emory Universitys strategic plan
6. Rockefeller Foundation will not abandon its commitments to public health
7. Hartford Foundation awards grant to address geriatric social work shortage
8. Clinton Foundation joins efforts in the fight against AIDS in Ukraine
9. The Starr Foundation launches multi-institutional cancer consortium
10. UTSA receives $225,000 National Science Foundation grant to support doctoral students in physics
11. NDRI receives Josiah Macy, Jr. Foundation grant

Post Your Comments:
(Date:5/20/2013)... CosmosID, a leading data mining solutions company for health ... results on analysis of labeling claims for the composition ... The Food and Drug Administration (FDA) and CosmosID conducted ... four of which have been reported at the American ... was to compare the identity of species and strains ...
(Date:5/20/2013)... Sporturf, an international manufacturer and builder of synthetic ... Midwest with the opening of the company’s third regional ... is under the leadership of President Craig Shonk, and ... , “This strategic move opens up a market ... Shonk. “Bringing an ISO manufacturer and a Midwest-based ASBA ...
(Date:5/20/2013)... Online education provides the convenience, flexibility and cost-saving ... According to the American Heart Association, 27% of ... to eLearning due to changing economic conditions. The ... budgets, but it is also proven to enhance ... higher retention of content is probable, given the ...
(Date:5/20/2013)... as a consequence of diabetic foot ulcer that does ... this situation are very limited. In his doctoral thesis ... Department of Medical Biochemistry and Biophysics at Ume University ... may completely change the lives of millions of patients. ... chronic wounds that largely impair the quality of life ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 BenefitMall, ... of employee benefit, payroll products and services and ... both are selected as finalists for the 2013 American ... Company of the Year category, and CompuPay is a ... finalist will ultimately be a Gold, Silver or Bronze ...
Breaking Medicine News(10 mins):Health News:CosmosID unveils new tool for faster, specific and accurate testing of probiotics products 2Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3
(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...
(Date:5/20/2013)... Enrollment of patients with Type 2 diabetes ... trial of product candidate NewMet ™, a delayed-release ... 2 diabetes. Elcelyx expects to complete enrollment of 240 ... of the trial,s primary endpoint of change in fasting ... read-out for long-term glucose lowering and weight benefits is ...
(Date:5/20/2013)... 20, 2013  AbbVie (NYSE: ABBV ... 3 clinical study called SONAR (Study Of Diabetic ... the investigational compound atrasentan - when added to standard ... patients with stage 2 to 4 chronic kidney ... a large, multinational, double-blind, placebo-controlled clinical study that ...
Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 2Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 3Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
Cached News: